Attenuation of doxorubicin cardiotoxicity and NADPH oxidase activation by the AT1 receptor antagonist, losartan.

Y. Zhao, D. McLaughlin, B.J. McDermott, David Grieve

Research output: Contribution to conferenceAbstractpeer-review

3 Citations (Scopus)
Original languageEnglish
PagesS130-S130
Number of pages1
Publication statusPublished - May 2010
EventInternational Society for Heart Research World Congress - Kyoto, Japan
Duration: 01 May 201001 May 2010

Conference

ConferenceInternational Society for Heart Research World Congress
CountryJapan
CityKyoto
Period01/05/201001/05/2010

Cite this